Children's National Medical Center

Conrad Russell Y Cruz

Catherine M Bollard

Raymond W Sze

Rohan Fernandes

Anthony Sandler

Matthieu F Dumont

Rachel Burga

Elizabeth E Sweeney

Sharon Lam

Juliana Cano-mejia

Combination treatment with Prussian blue nanoparticles and at least one immunotherapeutic treatment. Stable, functionalized Prussian blue nanoparticles, including those with enhanced stability under alkaline conditions, and methods of cancer, neoplasm, and tumor treatment using them, including photothermal treatment and combination immunotherapeutic treatments.

Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereof

Compositions for T cell-based immunotherapy of HIV, HIV-associated malignancies, HIV-associated viral infections, or other HIV-related complications. Modified T cells that are resistant to invasion or infection with HIV, such as T-cells modified to decrease or eliminate expression of mannosyl-oligosacharide glucosidase enzyme ('MOGS'). Methods for producing such compositions by expanding HIV-specific T cells from different sources to recognize multiple HIV antigens.

Generation of broadly-specific, virus-immune cells targeting multiple HIV antigens for preventive and therapeutic use

Growing community of inventors

Bethesda, MD, United States of America

Conrad Russell Y Cruz